SELL Honasa Consumer — J.P. Morgan, 17 Sept 2026

byJ.P. MorganHorizon: NA (inferred 1 year)17 Sept 2026via NDTV Profit

Entry₹471.8Inferred

Target₹410

Stop lossNot given

CMP₹479.55Just now

Active-1.64%+14.50%upside left 12 mo left

Follow J.P. Morgan for new calls(100% target hit, 10 closed calls)Get alerts Watch HONASA for new buy/sell callsGet alerts See 6 other Long-term calls on HONASA See 93 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 18 Sept, 4:46 pm IST

1 supporting5 neutral22 opposing

Supports the SELL call (1)

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·14 Aug · 1mo ago

Neutral / worth noting (5)

Mamaearth parent Honasa Consumer scraps 58% Fluence Pharma stake acquisition

NewsCnbc-Tv18·25 Aug · 3w ago

Honasa Consumer Ltd has provided an update regarding its proposed acquisition of Fluence Pharma Private Limited.

BSE · Company Update·25 Aug · 3w ago

Weighs against the SELL call (22)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·17 Sept · yesterday

Honasa Consumer elevates Nishchay Bahl as CBO-Offline amid strong stock rally

NewsHbl·8 Sept · 1w ago

Mamaearth Parent Honasa Consumer Targets Rs 5,500 Crore Revenue By FY31

NewsNdtv-Profit·4 Sept · 2w ago

Dividend alert! Last day to buy Paras Defence, MCX, 34 other stocks for payouts. Do you own any?

NewsEt-Markets·27 Aug · 3w ago

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·18 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.